News from the FDA/CDC

Flu now riding on COVID-19’s coattails


 

The viral tsunami that is COVID-19 has hit the United States, and influenza appears to be riding the crest of the wave.

Influenza-like illness activity level, week enidng March 14, 2020

Flu activity, in the form of visits to health care providers, increased for the second consecutive week after declining for the three previous weeks, according to the Centers for Disease Control. Flu-related visits went from 5.2% of all outpatient visits the week before to 5.8% during the week ending March 14.

“The COVID-19 outbreak unfolding in the United States may affect healthcare seeking behavior which in turn would impact data from” the U.S. Outpatient Influenza-like Illness Surveillance Network, the CDC explained.

Data from clinical laboratories show that, despite the increased activity, fewer respiratory specimens tested positive for influenza: 15.3% for the week of March 8-14, compared with 21.1% the week before, the CDC’s influenza division said in its latest FluView report.

Influenza activity also increased slightly among the states, with 35 states and Puerto Rico at the highest level on the CDC’s 1-10 scale, versus 34 states and Puerto Rico the previous week. The count was down to 33 for the last week of February, CDC data show.

Severity measures remain mixed as overall hospitalization continues to be moderate but rates for children aged 0-4 years and adults aged 18-49 years are the highest on record and rates for children aged 5-17 years are the highest since the 2009 pandemic, the influenza division said.

Mortality data present a similar picture: The overall death rate is low, but the 149 flu-related deaths reported among children is the most for this point of the season since 2009, the CDC said.

Recommended Reading

Lopinavir-ritonavir trial results ‘disappointing’ for severe COVID-19
Clinician Reviews
Real-world shortages not addressed in new COVID-19 guidance
Clinician Reviews
Standing by and still open for business during COVID-19 pandemic
Clinician Reviews
Rheumatologists to share knowledge in COVID-19 patient-centered registry
Clinician Reviews
20% of U.S. COVID-19 deaths were aged 20-64 years
Clinician Reviews
Feds tout drug candidates to treat COVID-19
Clinician Reviews
COVID-19 prompts ‘lifesaving’ policy change for opioid addiction
Clinician Reviews
DIY masks: Worth the risk? Researchers are conflicted
Clinician Reviews
New ASAM guideline released amid COVID-19 concerns
Clinician Reviews
Preventable diseases could gain a foothold because of COVID-19
Clinician Reviews